Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Non Operating Investment Income: 2010-2012

Historic Non Operating Investment Income for Altimmune (ALT) over the last 2 years, with Jun 2012 value amounting to $823,809.

  • Altimmune's Non Operating Investment Income rose 19.70% to $823,809 in Q2 2012 from the same period last year, while for Jun 2012 it was $3.8 million, marking a year-over-year increase of 247.20%. This contributed to the annual value of $7.1 million for FY2011, which is 230.92% up from last year.
  • Latest data reveals that Altimmune reported Non Operating Investment Income of $823,809 as of Q2 2012, which was up 183.07% from -$991,662 recorded in Q1 2012.
  • Altimmune's Non Operating Investment Income's 5-year high stood at $2.9 million during Q3 2011, with a 5-year trough of -$5.8 million in Q4 2010.
  • In the last 3 years, Altimmune's Non Operating Investment Income had a median value of $688,221 in 2011 and averaged $165,123.
  • Per our database at Business Quant, Altimmune's Non Operating Investment Income skyrocketed by 3,734.79% in 2011 and then crashed by 139.85% in 2012.
  • Over the past 3 years, Altimmune's Non Operating Investment Income (Quarterly) stood at -$5.8 million in 2010, then soared by 118.33% to $1.1 million in 2011, then grew by 19.70% to $823,809 in 2012.
  • Its last three reported values are $823,809 in Q2 2012, -$991,662 for Q1 2012, and $1.1 million during Q4 2011.